Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis
-
Published:2018-11
Issue:
Volume:103
Page:214-226
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
ter Veer EmilORCID,
van Kleef Jessy Joy,
Schokker SandorORCID,
van der Woude Stephanie O.,
Laarman Marety,
Haj Mohammad Nadia,
Sprangers Mirjam A.G.,
van Oijen Martijn G.H.,
van Laarhoven Hanneke W.M.
Funder
Dutch Cancer Society
Bayer
Lilly
Merck Serono
Roche
Philips
BMS
Celgene
MSD
Nordic
Subject
Cancer Research,Oncology
Reference83 articles.
1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol,2017
2. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis;Ter Veer;J Natl Cancer Inst,2016
3. Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature;Ter Veer;Cancer Metastasis Rev,2016
4. Chemotherapy for advanced gastric cancer;Wagner;Cochrane Database Syst Rev,2017
5. Prognostic factors versus predictive factors: examples from a clinical trial of erlotinib;Clark;Mol Oncol,2008
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献